Non-obstructive coronary artery disease (NOCAD) is commonly found on coronary computed
tomography angiography (CCTA) in patients undergoing evaluation of symptoms suggestive
of obstructive coronary artery disease (OCAD). Patients with NOCAD have an increased
risk of cardiovascular events, yet there is no consensus regarding the optimal use
of preventive cardiovascular medical therapy. We analyzed data from the PROMISE trial
to compare patterns of preventive medical therapy use and continuation after identifying
NOCAD, compared with OCAD or normal coronaries, on CCTA.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
036
Identification
Copyright
© 2020 Published by Elsevier Inc.
